Clinical trial

DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men

NCT03771638

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-02-01

PhasePHASE4

Study timeline

Study start (actual)2019-02-01Date precision: day

Registry last updated2025-07-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adherence, Medicationunresolved

Risk Behaviorunresolved

Pre-Exposure Prophylaxisunresolved

HIV Preventionunresolved

Interventions

Emtricitabine / Tenofovir Disoproxil Oral TabletDRUG · verified · RxNorm: emtricitabine / tenofovir disoproxil Oral Tablet

DOT Diary mobile appOTHER

Sponsors & collaborators

Public Health Foundation Enterprises, Inc.lead sponsor

National Institute of Mental Health (NIMH)collaborator

San Francisco Department of Public Healthcollaborator

Emory Universitycollaborator

AiCurecollaborator

Mapped research locations

AtlantaGeorgia, United States1 San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03771638 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.